Literature DB >> 25802489

Angiogenesis QTL on Mouse Chromosome 8 Colocalizes with Differential β-Defensin Expression.

Jason Smith1, Fang Liu1, Barbara Beyer1, Krista Morales1, Andrew Reilly1, Richard Cole1, Bruce J Herron1.   

Abstract

Identification of genetic factors that modify complex traits is often complicated by gene-environment interactions that contribute to the observed phenotype. In model systems, the phenotypic outcomes quantified are typically traits that maximize observed variance, which in turn, should maximize the detection of quantitative trait loci (QTL) in subsequent mapping studies. However, when the observed trait is dependent on multiple interacting factors, it can complicate genetic analysis, reducing the likelihood that the modifying mutation will ultimately be found. Alternatively, by focusing on intermediate phenotypes of a larger condition, we can reduce a model's complexity, which will, in turn, limit the number of QTL that contribute to variance. We used a novel method to follow angiogenesis in mice that reduces environmental variance by measuring endothelial cell growth from culture of isolated skin biopsies that varies depending on the genetic source of the tissue. This method, in combination with a backcross breeding strategy, is intended to reduce genetic complexity and limit the phenotypic effects to fewer modifier loci. We determined that our approach was an efficient means to generate recombinant progeny and used this cohort to map a novel s.c. angiogenesis QTL to proximal mouse chromosome (Chr.) 8 with suggestive QTL on Chr. 2 and 7. Global mRNA expression analysis of samples from parental reference strains revealed β-defensins as potential candidate genes for future study.

Entities:  

Keywords:  genetics; mouse model; skin development

Mesh:

Substances:

Year:  2015        PMID: 25802489      PMCID: PMC4365986          DOI: 10.7171/jbt.15-2602-002

Source DB:  PubMed          Journal:  J Biomol Tech        ISSN: 1524-0215


  33 in total

1.  Custom CGH array profiling of copy number variations (CNVs) on chromosome 6p21.32 (HLA locus) in patients with venous malformations associated with multiple sclerosis.

Authors:  Alessandra Ferlini; Matteo Bovolenta; Marcella Neri; Francesca Gualandi; Alessandra Balboni; Anton Yuryev; Fabrizio Salvi; Donato Gemmati; Alberto Liboni; Paolo Zamboni
Journal:  BMC Med Genet       Date:  2010-04-28       Impact factor: 2.103

2.  R/qtl: high-throughput multiple QTL mapping.

Authors:  Danny Arends; Pjotr Prins; Ritsert C Jansen; Karl W Broman
Journal:  Bioinformatics       Date:  2010-10-21       Impact factor: 6.937

3.  Linkage to 20p13 including the ANGPT4 gene in families with mixed Alzheimer's disease and vascular dementia.

Authors:  Anna Sillén; Jesper Brohede; Lena Lilius; Charlotte Forsell; Jorge Andrade; Jacob Odeberg; Hayao Ebise; Bengt Winblad; Caroline Graff
Journal:  J Hum Genet       Date:  2010-07-01       Impact factor: 3.172

4.  Identification of cis- and trans-acting genetic variants explaining up to half the variation in circulating vascular endothelial growth factor levels.

Authors:  Stephanie Debette; Sophie Visvikis-Siest; Ming-Huen Chen; Ndeye-Coumba Ndiaye; Ci Song; Anita Destefano; Radwan Safa; Mohsen Azimi Nezhad; Douglas Sawyer; Jean-Brice Marteau; Vanessa Xanthakis; Gerard Siest; Lisa Sullivan; Michele Pfister; Holly Smith; Seung-Hoan Choi; John Lamont; Lars Lind; Qiong Yang; Peter Fitzgerald; Erik Ingelsson; Ramachandran S Vasan; Sudha Seshadri
Journal:  Circ Res       Date:  2011-07-14       Impact factor: 17.367

Review 5.  Quantitative trait locus analysis using J/qtl.

Authors:  Randy Smith; Keith Sheppard; Keith DiPetrillo; Gary Churchill
Journal:  Methods Mol Biol       Date:  2009

6.  Mouse β-defensin 14 (Defb14) promotes tumor growth by inducing angiogenesis in a CCR6-dependent manner.

Authors:  Johann Röhrl; Barbara Huber; Gudrun E Koehl; Edward K Geissler; Thomas Hehlgans
Journal:  J Immunol       Date:  2012-04-13       Impact factor: 5.422

7.  Genetic heterogeneity of skin microvasculature.

Authors:  Fang Liu; Jason Smith; Zhen Zhang; Richard Cole; Bruce J Herron
Journal:  Dev Biol       Date:  2010-02-17       Impact factor: 3.582

8.  Mouse and human strategies identify PTPN14 as a modifier of angiogenesis and hereditary haemorrhagic telangiectasia.

Authors:  Michael Benzinou; Frederic F Clermont; Tom G W Letteboer; Jai-Hyun Kim; Silvia Espejel; Kelly A Harradine; Juan Arbelaez; Minh Thu Luu; Ritu Roy; David Quigley; Mamie Nakayama Higgins; Musa Zaid; Bradley E Aouizerat; Johannes Kristian Ploos van Amstel; Sophie Giraud; Sophie Dupuis-Girod; Gaetan Lesca; Henri Plauchu; Christopher C W Hughes; Cornelius J J Westermann; Rosemary J Akhurst
Journal:  Nat Commun       Date:  2012-01-10       Impact factor: 14.919

Review 9.  Human defensins as cancer biomarkers and antitumour molecules.

Authors:  Nathalie Droin; Jean-Baptiste Hendra; Patrick Ducoroy; Eric Solary
Journal:  J Proteomics       Date:  2009-01-11       Impact factor: 4.044

Review 10.  Targeting angiogenesis: progress with anti-VEGF treatment with large molecules.

Authors:  Axel Grothey; Evanthia Galanis
Journal:  Nat Rev Clin Oncol       Date:  2009-07-28       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.